Flexion Therapeutics, Inc. (FLXN) Reaches $21.92 Formed H&S; French Connection Group plc (LON:FCCN) Had 1 Bullish Analysts

Among 2 analysts covering French Connection Group PLC (LON:FCCN), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. French Connection Group PLC had 14 analyst reports since September 21, 2015 according to SRatingsIntel. Numis Securities maintained the stock with “Buy” rating in Tuesday, September 19 report. As per Monday, September 21, the company rating was maintained by Cantor Fitzgerald. On Tuesday, March 14 the stock rating was maintained by Numis Securities with “Buy”. The rating was maintained by Numis Securities with “Add” on Tuesday, March 15. The firm has “Hold” rating by Cantor Fitzgerald given on Tuesday, March 15. The firm has “Hold” rating by Cantor Fitzgerald given on Thursday, September 21. The firm has “Hold” rating given on Monday, December 7 by Cantor Fitzgerald. The rating was upgraded by Numis Securities on Tuesday, September 20 to “Buy”. Cantor Fitzgerald maintained it with “Hold” rating and GBX 45 target in Tuesday, September 20 report. The stock has “Hold” rating by Cantor Fitzgerald on Tuesday, March 14. See French Connection Group plc (LON:FCCN) latest ratings:

21/09/2017 Broker: Cantor Fitzgerald Rating: Hold Old Target: GBX 40.00 New Target: GBX 45.00 Maintain
19/09/2017 Broker: Numis Securities Rating: Buy Old Target: GBX 55.00 New Target: GBX 55.00 Maintain

Flexion Therapeutics, Inc. (FLXN) formed H&S with $20.82 target or 5.00% below today’s $21.92 share price. Flexion Therapeutics, Inc. (FLXN) has $822.89M valuation. The stock decreased 2.75% or $0.62 during the last trading session, reaching $21.92. About 1.21M shares traded or 30.44% up from the average. Flexion Therapeutics, Inc. (NASDAQ:FLXN) has risen 82.02% since February 10, 2017 and is uptrending. It has outperformed by 65.32% the S&P500.

French Connection Group PLC designs, produces, and distributes branded fashion clothing for men, women, and children. The company has market cap of 29.36 million GBP. The firm also provides toiletries and fragrances, shoes, watches, jewelry, eyewear, and furniture, as well as accessories and homeware products. It currently has negative earnings. It operates retail stores and concessions in the United Kingdom, Europe, the United States, and Canada; and e-commerce stores.

The stock decreased 1.61% or GBX 0.5 during the last trading session, reaching GBX 30.5. About 27,125 shares traded. French Connection Group plc (LON:FCCN) has 0.00% since February 10, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 10 analysts covering Flexion Therapeutics (NASDAQ:FLXN), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Flexion Therapeutics had 22 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by Cantor Fitzgerald on Monday, June 12 with “Buy”. The stock of Flexion Therapeutics, Inc. (NASDAQ:FLXN) has “Buy” rating given on Friday, September 15 by Needham. On Monday, September 11 the stock rating was maintained by RBC Capital Markets with “Buy”. As per Monday, October 30, the company rating was maintained by Wells Fargo. Lake Street initiated the shares of FLXN in report on Thursday, July 21 with “Buy” rating. BMO Capital Markets maintained Flexion Therapeutics, Inc. (NASDAQ:FLXN) on Monday, June 26 with “Buy” rating. The firm has “Buy” rating given on Wednesday, November 4 by Cantor Fitzgerald. The firm earned “Outperform” rating on Monday, October 9 by BMO Capital Markets. The stock of Flexion Therapeutics, Inc. (NASDAQ:FLXN) earned “Buy” rating by RBC Capital Markets on Tuesday, October 24. The company was initiated on Wednesday, June 29 by BMO Capital Markets.